Archive 2005

Archive 2004

12.20.04	PharmaGap Closes Private Placement
12.14.04	Increase In PharmaGap Private Placement
12.06.04	Rod Bryden To Direct PharmaGap Inc./Appointment of New Executive Team
11.25.04	Third Quarter Results/Encouraging Results For Cancer Drug /Initiates Private Equity Placement
08.27.04	Appointment of Chairman and Managing Director
08.26.04	PharmaGap Inc. Amends Warrants of May 1, 2003 Private Placement
06.28.04	PharmaGap’s President Announces Operational Review
06.01.04	Novel Assay to Measure the Potential of Animals to Resist Virus infections
05.28.04	PharmaGap Releases First Quarter 2004 & Year End 2003 Financial Statements
04.28.04	PharmaGap & In Silico Pharma Announce Drug Development Collaboration
04.19.04	Notice of Annual General Meeting
02.04.04	PharmaGap Announces the Availability of its Immuno-Resistance Assay for Poultry
01.15.04	PharmaGap To Provide Its Unique 3-D Cell Model to a “Top 5” U.S. Pharmaceutical Company
01.07.04	PharmaGap and Intervet Announce a Collaborative Research Agreement